The invention generally relates to the detection of pathogens. More particularly, illustrative embodiments are directed to a method and apparatus for the quantitative genetic detection of pathogens such as MTB DNA on a paper hybrid device using a thermometer.
Many pathogens frequently cause global health concerns. Tuberculosis (TB), one of the deadliest infectious diseases, remains a leading cause of death from a single infection across the world. High morbidity and mortality of TB pose a significant threat to public health, causing nearly 1.5 million deaths annually.
TB is caused by a species of pathogenic bacteria, Mycobacterium tuberculosis (MTB), which has been traditionally diagnosed via time-consuming clinical examination, sputum smear microscopy, and culture of MTB bacteria. Recent years have seen a rapid development of laboratory diagnostics for TB based on molecular tests, typically MTB DNA detection methods, which significantly facilitate early diagnosis of TB, especially for latent infection. Latent TB usually happens at an early stage of infection, where MTB is internalized into the phagosomes of host macrophages and exhibits latency. However, the latent TB becomes active when MTB starts to replicate after rupturing the phagosomal membranes and translocating into the cytosol. Researchers have found two types of genes (EsxA and EsxB) and their encoding secreted proteins (6-kDa early secreted antigenic target or ESAT-6, and 10-kDa culture filtrate protein or CFP-10) play an important role in the transition from latent TB to active. Therefore, these genes can be used as specific targets for MTB DNA detection.
To date, various MTB DNA detection methods have been developed, including colorimetry, electrochemistry, fluorescence, chemiluminescence, etc, which generally rely on DNA amplification techniques, such as polymerase chain reaction (PCR), and loop-mediated isothermal amplification (LAMP). For instance, clinical samples were detected quantitatively based on the colorimetric method using PCR-amplified MTB DNA, which was based on the target-induced nanoprobe aggregation.
Illustrative embodiments provide a low-cost photothermal biosensing method for the quantitative genetic detection of pathogens such as MTB DNA on a paper hybrid device using a thermometer. First, DNA capture probes were simply immobilized on paper through a one-step surface modification process. After DNA sandwich hybridization, oligonucleotide-functionalized gold nanoparticles (AuNPs) were introduced on paper and then catalyzed the oxidation reaction of 3,3′,5,5′-tetramethylbenzidine (TMB). The produced oxidized TMB, acting as a strong photothermal agent, was used for the photothermal biosensing of MTB DNA under 808 nm laser irradiation. Under optimal conditions, the on-chip quantitative detection of the target DNA was readily achieved using an inexpensive thermometer as a signal recorder. Illustrative embodiments do not require any expensive analytical instrumentation, but can achieve higher sensitivity and there are no color interference issues, compared to conventional colorimetric methods. The method was further validated by detecting genomic DNA with high specificity. Illustrative embodiments provide photothermal biosensing for quantitative nucleic acid analysis on microfluidics using a thermometer, which brings new inspirations on the development of simple, low-cost, and miniaturized photothermal diagnostic platforms for quantitative detection of a variety of diseases at the point of care.
According to an embodiment of this disclosure, a method of quantitative genetic detection of a pathogen, comprises: immobilizing a genetic capture probe on a substrate; capturing genetic material from the pathogen using the genetic capture probe; performing sandwich hybridization of the genetic capture probe, the captured genetic material and a detector probe further comprising a nanomaterial catalyst to form a conjugate; contacting the conjugate with a photothermal agent; oxidizing the photothermal agent using the nanomaterial catalyst conjugated on the detector probe to form an oxidized photothermal agent; exposing the oxidized photothermal agent to actinic energy; and measuring a temperature increase caused by heat from the exposed oxidized photothermal agent using a thermometer to quantify the pathogen.
According to another embodiment of this disclosure, an apparatus for quantitative genetic detection of a pathogen, comprises: a substrate; a genetic capture probe immobilized on the substrate; genetic material from the pathogen captured by the genetic capture probe; a detector probe sandwich hybridized with the captured genetic material from the pathogen and the capture probe, the detector probe further comprising a nanomaterial catalyst to form a conjugate; a photothermal agent oxidized using the nanomaterial catalyst conjugated on the detector probe; a laser configured to expose the oxidized photothermal agent to actinic energy; and a thermometer configured to measure a temperature increased cause by heat from the exposed oxidized photothermal agent to quantify the pathogen.
According to another embodiment of this disclosure, a device for quantitative genetic detection of a pathogen, comprises: a substrate; a genetic capture probe immobilized by the substrate; genetic material from the pathogen captured on the genetic capture probe; a detector probe sandwich hybridized with the captured genetic material from the pathogen and the capture probe, the detector probe further comprising a nanomaterial catalyst to form a conjugate; and a photothermal agent oxidized using the nanomaterial catalyst conjugated on the detector probe.
The descriptions of the various embodiments of the present invention have been presented for purposes of illustration, but are not intended to be exhaustive or limited to the embodiments disclosed. Not all embodiments will include all of the features described in the illustrative examples. Further, different illustrative embodiments may provide different features as compared to other illustrative embodiments. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiment. The terminology used herein was chosen to best explain the principles of the embodiment, the practical application or technical improvement over technologies found in the marketplace, or to enable others of ordinary skill in the art to understand the embodiments disclosed here.
The novel features believed characteristic of the illustrative embodiments are set forth in the appended claims. The illustrative embodiments, however, as well as a preferred mode of use, further objectives and features thereof, will best be understood by reference to the following detailed description of an illustrative embodiment of the present disclosure when read in conjunction with the accompanying drawings, wherein:
The illustrative embodiments recognize and take into account one or more different considerations. For example, the illustrative embodiments recognize and take into account that current MTB DNA detection methods require expensive analytical instruments and professional operators, which have significantly increased the complexity and cost of TB diagnoses and limited their wide accessibility, especially in low-resource settings. Therefore, it is still challenging and demanding to develop new detection strategies for low-cost and quantitative detection of MTB DNA.
Recently, nanomaterial-mediated photothermal biosensing methods have emerged as an attractive strategy in the quantitative detection of biomolecules, due to the simplicity in the experimental process (such as no need for pneumatic pumps), low cost in data recoding (only using a thermometer as a signal reader), and great convenience in analyzing biosensing signals (temperature-based readouts). Several photothermal biosensing platforms have been developed for the detection of biomolecules. By converting the traditional immunosensing signals to photothermal signals (i.e., temperature), biomolecules are quantified by only using a common thermometer. For instance, a photothermal immunoassay using a common thermometer for quantitative cancer biomarker detection has been developed. However, most of the current photothermal biosensing strategies have focused on protein analysis, while photothermal genetic analysis is rarely reported.
Microfluidic lab-on-a-chip (LOC) technology has provided a promising point-of-care (POC) diagnostic tool for various diseases, owing to its miniaturization, portability, low reagent consumption, etc. Among numerous LOC devices, paper-based microfluidic devices have attracted much attention given the merits of paper substrates, such as the extremely low cost, ease of manipulation, and 3D porous microstructures with a high surface-to-volume ratio. Particularly, by integrating them with other materials, such as rigid polymers, the obtained paper/polymer hybrid microfluidic devices have been capable of meeting assorted requirements for sample immobilization, fluid processing, and signal analyzing, which are suitable for easy and inexpensive nucleic acid analysis at the point of care. For example, a simple, low-cost, and versatile paper-based device has been developed for genetic analysis via a one-step surface modification method using 3-aminopropyl trimethoxysilane (APTMS). The nonfunctionalized DNA probes are directly immobilized on paper through ionic interaction between the negatively charged DNA probes and positively charged paper surface. Enhanced DNA immobilization efficiency and detection sensitivity are obtained using the paper substrate. However, this low-cost paper-based microfluidic platform has not been integrated with photothermal biosensing for quantitative DNA detection. Illustrative embodiments provide a new photothermal biosensing method on a paper hybrid microfluidic device for the low-cost quantitative detection of MTB DNA using a thermometer. Target MTB DNA (derived from the MTB EsxA gene) is recognized via the sandwich hybridization between capture DNA probes and AuNP-modified detector probes, where the former is immobilized on the paper substrate after one-step surface modification. The paper substrate can be located within a paper hybrid microfluidic device. The near-infrared (NIR) photothermal agent, oxidized 3,3′,5,5′-tetramethylbenzidine (ox-TMB), is then produced based on the AuNP-catalyzed TMB oxidization reaction, which further converts target concentration information to temperature readouts under the irradiation of an 808 nm laser. In general, embodiments of this disclosure can use one or more lasers that generate near infrared laser irradiation. By only using a thermometer, the quantification of target DNA is achieved from the on-chip temperature measurement.
Illustrative embodiments integrate the photothermal biosensing strategy on a paper hybrid microfluidic device for simple, low-cost, and quantitative detection of DNA. In comparison with conventional colorimetric methods, illustrative embodiments provide higher sensitivity with no issues of color interference, while preventing the need for advanced analytical instruments.
Following, without limitation, are examples of materials and instruments used in illustrative embodiments. Illustrative embodiments are not limited to the particular materials and instruments and sources thereof listed herein.
Whatman No. 1 chromatography paper, gold nanoparticles (with the diameter of 20 nm), 3,3′,5,5′-tetramethylbenzidine (TMB), tris (2-carboxyethyl) phosphine hydrochloride (TCEP), (3-aminopropyl) trimethoxysilane (APTMS), bovine serum albumin (BSA), saline-sodium citrate (SSC) buffer (20×, pH 7.0), sodium dodecyl sulfate (SDS), and phosphate-buffered saline (PBS, 10 mM, pH 7.4) purchased from Sigma (St. Louis, Mo., USA). Hydrogen peroxide (H2O2, 30% w/w) purchased from Fisher Scientific (Hampton, N.H., USA). Poly (methyl methacrylate) (PMMA, 2.0 mm in thickness) sheets purchased from Mcmaster-Carr (Los Angeles, Calif., USA). All chemicals used as received without further purification. All buffer solutions prepared by diluting in PBS buffer, including the washing buffer (2×SSC, 0.1% SDS) and the hybridization buffer (5×SSC, 0.1% SDS, 1% BSA).
Synthetic oligonucleotide sequences were purchased from Integrated DNA Technologies (Coralville, Iowa, US) and listed in Table Sl. The genomic nucleic acid species were provided by Prof. Jianjun Sun's lab (UTEP), including Mycobacterium tuberculosis (MTB), Mycobacterium smegmatis (M. smegmatis), Mycobacterium marinum (M. marinum), and MTB (ΔEsxAB) (the MTB strain with deletion of EsxB:EsxA operon, denoted as TB Knockout herein). The concentrations of DNA samples were determined via a NanoDrop spectrophotometer (Sigma-Aldrich, St. Louis, Mo., USA).
UV-vis characterization was performed on a microplate reader (Molecular Devices, LLC, Sunnyvale, Calif., US). The 808 nm diode laser (Model MDL-808, Opto Engine, Midvale, Utah, US) was used to irradiate samples. The on-chip temperature measurement was obtained by using a digital thermometer (e.g. Model 421502, Extech Instruments Corporation, US). The thermometer has a resolution of 0.1° C. and was used as a signal recorder for the following photothermal biosensing process.
The DNA probe-AuNP conjugates were prepared freshly modified from a published procedure via the typical salt-aging method. Firstly, 3 μL of 100 μM thiolated DNA (SH-DNA) probes were added into a TCEP aqueous solution (6 μL, 100 μM), followed by incubation at room temperature for 30 min. The mixture was then added to 1.0 mL of AuNPs (1.2 nM) and incubated overnight. Aliquots of 120 μL 1% SDS and 12 μL 2 M NaCl were added to the suspension slowly, followed by further incubation for 24 h. The obtained suspension was centrifuged at 13000 rpm for 20 min and washed three times with the washing buffer. The pellet was finally dispersed in PBS buffer (10 mM, pH 7.4, 150 mM NaCl, 0.1% SDS) and stored at 4° C. The synthesized DNA probe-AuNP conjugates were characterized via UV-vis spectroscopy, and the concentration of AuNPs was determined using the Beer-Lambert law.
The paper/polymer hybrid microfluidic device was designed with the Adobe AI software and fabricated using chromatography paper and PMMA sheets. Essentially, PMMA sheets were laser ablated using a laser cutter (Epilog laser, Golden, Colo.), yielding six reservoirs with a diameter of 3.5 mm and a depth of 1.5 mm for each. The chromatography paper was cut on the laser cutter to form circular regions with a diameter of 3.5 mm, and then inserted into PMMA reservoirs. The whole size of the paper/PMMA hybrid device was 75 mm×18 mm.
To immobilize capture probes on the paper substrate, a surface modification process was adapted based on a reported method. Firstly, 10 μL of 5% APTMS was added to each paper reservoir and incubated for 10 min. After washing thoroughly, the device was dried under ambient temperature. On each APTMS-modified detection zone, 5 μL of 1 μM capture probes were added and incubated for 30 min at 37° C. A BSA solution (3%, w/v) was then added as the blocking reagent and incubated for 10 min at 37° C. The DNA probe-AuNP conjugates and target MTB DNA with varying concentrations were mixed in a volume ratio of 1:1 and prehybridized for 30 min at 37° C. The obtained solution was added to the device with 10 μL per reservoir and incubated for 30 min at 37° C. Notably, washing steps were performed after each incubation step to remove nonspecific binding. Additionally, when using genomic DNA, the samples were firstly denatured at 95° C. for 5 min and then placed on ice for 1 min before the prehybridization step.
After DNA hybridization, the substrate mixture containing TMB (0.25 mg/mL), H2O2 (1.25 M), and the citrate buffer, was added (20 μL per reservoir) and allowed to react for 20 min at room temperature. The 808 nm laser was then used to irradiate each reservoir with a power density of 0.16 W/mm2. The irradiation setup was carefully adjusted to achieve comparable sizes between the NIR laser spot and detection reservoirs with a diameter of 3.5 mm. On-chip temperature measurement was conducted using the thermometer immediately after irradiation. The position of the digital thermometer with a miniaturized probe tip (1.0 mm of diameter) was fixed in all photothermal biosensing process to avoid temperature variations due to position changes.
The working principle for photothermal detection of MTB DNA on a paper hybrid device 116 is shown in
As illustrated in
The feasibility of the AuNP-mediated photothermal biosensing method in accordance with an illustrative embodiment was investigated by testing different components in the system, and the results are shown in
No obvious differences were observed in the UV-vis spectra and photographs of the Samples (a-f) (containing incomplete component combinations in the AuNP-catalyzed TMB oxidization reaction system), whereas an absorption peak 210 at around 650 nm appeared in Sample (g) (containing all components in the AuNP-catalyzed TMB oxidization reaction system) with a clear blue color. It is noted that the characteristic peak of AuNPs (20 nm) at 520 nm is not shown in Sample (c) due to the extremely low concentration (i.e., 0.03 nM), as compared to AuNPs at a higher concentration (i.e., 0.8 nM) in
In this nanomaterial-mediated photothermal biosensing platform, TMB was used with the substrate to produce the photothermal biosensing probe (i.e., ox-TMB), and it is desirable for the concentration of TMB to be optimized in order to achieve the best detection performance. The off-chip UV-vis spectroscopy and on-chip temperature measurement were applied to characterize the optimization process. Generally, given a constant concentration of AuNPs (0.8 nM) and the reaction time (20 min), a series of TMB concentrations in the range from 0 to 1.5 mg/mL were tested. As seen in
To obtain the maximum amount of ox-TMB, the concentration of the catalyst (AuNPs) in this TMB oxidization reaction system was also optimized for the best photothermal biosensing performance. By testing different concentrations (0-1.5 nM) of AuNPs, the off-chip UV-vis spectra and on-chip temperature measurement were applied to characterize the optimization process under the optimal concentration (0.25 mg/mL) of TMB. The absorbances at 650 nm and 810 nm were selected representing the typical peaks of the colorimetric and the NIR photothermal absorption. As shown in
In the following AuNP-mediated photothermal biosensing of the target DNA, the DNA probe-AuNP conjugates instead of bare AuNPs were used as the catalyst for the photothermal biosensing probe (ox-TMB). It is worth noting that the DNA probe-AuNP conjugates were synthesized at a constant concentration ratio between the DNA probes and bare AuNPs. The characterization of the conjugates was conducted via UV-vis spectroscopy. A peak shift from 520 nm to 530 nm occurred for the conjugates in comparison with bare AuNPs (0.8 nM), which is attributed to the change of surface charges after bioconjugation with oligonucleotides.50 The concentration of AuNPs in the obtained conjugates was calculated using the Beer-Lambert law based on the extinction coefficient of 8.78×108 M-1·cm-1, and the concentration of conjugated DNA probes was confirmed using the NanoDrop spectrophotometer according to the absorbance at 260 nm. The final molar concentration ratio of the DNA probe-AuNP conjugates was obtained as 220:1 (DNA probes: AuNPs) in the photothermal genetic analysis platform.
To characterize the effect of the irradiation time and obtain the maximum temperature signals, kinetic studies were conducted for the photothermal biosensing of the target DNA. Under continuous laser irradiation, the dynamic temperature changes of both the control 510 (in the absence of target DNA) and a sample 520 (in the presence of 10 μM target DNA) were monitored for 6 min. The results are shown in
Under optimal conditions, the on-chip photothermal detection of MTB DNA was performed by recording temperature increases of samples using a thermometer. A series of different concentrations in the range of 0-50 μM for synthetic MTB DNA samples were tested. Insets (a-b) in
It is noted that in comparison with conventional colorimetric biosensing methods, there are several significant advantages in our photothermal detection method. First, the proposed method provides higher sensitivity for the detection of target DNA, obtaining a lower LOD value (0.58 μg/mL) than those reported based on colorimetric signals (LODs: 10 μg/mL, 1.88 μg/mL, or 1.14 μg/mL). In addition, with only a simple and inexpensive signal reader (a thermometer), quantitative detection of DNA can be achieved, avoiding the need for bulky and expensive instruments (such as spectrometers) and significantly reducing the bioassay cost. Furthermore, the quantification of DNA is based on temperature readouts, thereby avoiding color interference from the sample matrix, which is usually a common problem in colorimetric biosensing methods in testing colored real samples, such as blood matrices. Herein, we used a food dye (red color) to mimic the real colored matrix of a blood sample, and observation of expected blue colored ox-TMB products was interfered with remarkably due to the red colored mimic matrix background. For instance, the inset (c) in
Referring to
Referring to
Referring to
Illustrative embodiments provide a low-cost photothermal biosensing method for visual quantitative nucleic acid detection on a paper hybrid device using a thermometer. By applying the AuNP-mediated photothermal effect in bioassays, the target DNA is quantitatively detected using temperature signals as analytical readouts, achieving higher sensitivity with no color interference, contrasting that from conventional colorimetric detection methods. The entire assay for the quantitative detection of MTB DNA as a model target can be completed within 2 h on a low-cost paper/polymer hybrid device (the material cost of $0.08 for each device), without the need for any costly instrumentation and complicated nucleic acid amplification procedures. This method was further validated by detecting genomic DNA with high specificity. Illustrative embodiments perform photothermal genetic analysis on paper hybrid microfluidic devices, providing a simple, low-cost, rapid, and quantitative photothermal microfluidic biosensing platform. With the rapid development of commercially available portable lasers, the portability of this photothermal platform will be further enhanced.
Since this photothermal genetic biosensing platform is based on nucleic acid hybridization, it may be useful in a wide range of biological applications based on conventional DNA hybridization techniques such as DNA microarray. Although the DNA microarray technique can provide high throughput, it usually requires costly fluorescence scanners. The illustrative embodiments outperforms conventional DNA microarray (e.g. using glass slides as substrates) in genetic analysis in terms of the aspects of simplicity, ease of operation, affordability, etc. The combination of all these significant features with a low-cost and portable paper hybrid microfluidic device make it particularly suitable for POC applications. Many new complementary genetic assays using a thermometer as the signal reader may be developed. Overall, considering genetic analysis is widely used in various biological applications including infectious disease diagnosis, this photothermal biosensing platform has great potential for broad applications, such as POC disease diagnosis, especially in resource-poor settings.
The description of the different illustrative embodiments has been presented for purposes of illustration and description and is not intended to be exhaustive or limited to the embodiments in the form disclosed. The different illustrative examples describe components that perform actions or operations. In an illustrative embodiment, a component can be configured to perform the action or operation described. For example, the component can have a configuration or design for a structure that provides the component an ability to perform the action or operation that is described in the illustrative examples as being performed by the component. Further, To the extent that terms “includes”, “including”, “has”, “contains”, and variants thereof are used herein, such terms are intended to be inclusive in a manner similar to the term “comprises” as an open transition word without precluding any additional or other elements.
The descriptions of the various embodiments of the present invention have been presented for purposes of illustration, but are not intended to be exhaustive or limited to the embodiments disclosed. Not all embodiments will include all of the features described in the illustrative examples. Further, different illustrative embodiments may provide different features as compared to other illustrative embodiments. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiment. The terminology used herein was chosen to best explain the principles of the embodiment, the practical application or technical improvement over technologies found in the marketplace, or to enable others of ordinary skill in the art to understand the embodiments disclosed here.
Referring to the application data sheet filed herewith, this application claims a benefit of priority under 35 U.S.C. 119(e) from co-pending provisional patent application U.S. Ser. No. 63/087,709, filed Oct. 5, 2020, the entire contents of which are hereby expressly incorporated herein by reference for all purposes.
Number | Date | Country | |
---|---|---|---|
63087709 | Oct 2020 | US |